Court Refuses Ranbaxy Rehearing Bid In Lipitor Case
Ending another chapter in Pfizer Inc. and Ranbaxy Laboratories' protracted battle over a generic version of blockbuster cholesterol drug Lipitor, an appeals court on Monday denied Ranbaxy's petition for rehearing a...To view the full article, register now.
Already a subscriber? Click here to view full article